One of the things we're excited about is: How can real-world data help accelerate how quickly we can understand those? Here are some of the new uses of GLP-1 drugs that are being explored, based on hints from real-world patient records
DOI: Published online: April 1, 2024 Department of Endocrinology, Affiliated Hospital of Jiangsu University, Zhenjiang, China Corresponding authors: Guoyue Yuan Department of Endocrinology, Affiliated Hospital of Jiangsu University, Zhenjiang 212001, China E-mail: [email protected] Xia Deng Department of Endocrinology, Affiliated Hospital of Jiangsu University, Zhenjiang 212001, China E-mail: [email protected] Copyright 2024 Korean Diabetes Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited
While direct clinical trial data for sublingual formulations is limited, providers report similar trajectories when equivalent drug exposure is achieved
The microbiota-gut-brain axis Physiological Reviews 2019;99(4):1877-2013
